Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3458 | 1904 | 43.8 | 87% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SIV | Author keyword | 49 | 24% | 9% | 176 |
| 2 | SHIV | Author keyword | 34 | 43% | 3% | 60 |
| 3 | SIMIAN IMMUNODEFICIENCY VIRUS | Author keyword | 26 | 26% | 4% | 85 |
| 4 | JOURNAL OF MEDICAL PRIMATOLOGY | Journal | 22 | 12% | 10% | 182 |
| 5 | MARION MERRELL DOW VIRAL PATHOGENESIS | Address | 12 | 45% | 1% | 20 |
| 6 | AIDS VACCINE SURVEILLANCE SYSTEM AVSS | Author keyword | 11 | 100% | 0% | 6 |
| 7 | SIVMAC | Author keyword | 7 | 48% | 1% | 11 |
| 8 | SIVCPZ | Author keyword | 7 | 67% | 0% | 6 |
| 9 | PRIMATE MODELSAKYO KU | Address | 6 | 53% | 0% | 8 |
| 10 | AIDS ABORATING | Address | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SIV | 49 | 24% | 9% | 176 | Search SIV | Search SIV |
| 2 | SHIV | 34 | 43% | 3% | 60 | Search SHIV | Search SHIV |
| 3 | SIMIAN IMMUNODEFICIENCY VIRUS | 26 | 26% | 4% | 85 | Search SIMIAN+IMMUNODEFICIENCY+VIRUS | Search SIMIAN+IMMUNODEFICIENCY+VIRUS |
| 4 | AIDS VACCINE SURVEILLANCE SYSTEM AVSS | 11 | 100% | 0% | 6 | Search AIDS+VACCINE+SURVEILLANCE+SYSTEM+AVSS | Search AIDS+VACCINE+SURVEILLANCE+SYSTEM+AVSS |
| 5 | SIVMAC | 7 | 48% | 1% | 11 | Search SIVMAC | Search SIVMAC |
| 6 | SIVCPZ | 7 | 67% | 0% | 6 | Search SIVCPZ | Search SIVCPZ |
| 7 | LIVE ATTENUATED SIV | 6 | 100% | 0% | 4 | Search LIVE+ATTENUATED+SIV | Search LIVE+ATTENUATED+SIV |
| 8 | SIVAGM | 5 | 47% | 0% | 8 | Search SIVAGM | Search SIVAGM |
| 9 | SOOTY MANGABEY | 5 | 50% | 0% | 7 | Search SOOTY+MANGABEY | Search SOOTY+MANGABEY |
| 10 | SIV MACAQUE MODEL | 4 | 75% | 0% | 3 | Search SIV+MACAQUE+MODEL | Search SIV+MACAQUE+MODEL |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SIMIAN IMMUNODEFICIENCY VIRUS | 107 | 21% | 23% | 442 |
| 2 | TANTALUS MONKEYS | 65 | 95% | 1% | 21 |
| 3 | CERCOCEBUS ATYS | 63 | 81% | 2% | 38 |
| 4 | AFRICAN GREEN MONKEYS | 61 | 31% | 9% | 164 |
| 5 | SOOTY MANGABEYS | 49 | 38% | 5% | 104 |
| 6 | VACCINE PROTECTION | 48 | 60% | 3% | 53 |
| 7 | NEF GENE | 44 | 42% | 4% | 80 |
| 8 | RHESUS MACAQUES | 44 | 11% | 19% | 359 |
| 9 | SEROEPIDEMIOLOGIC SURVEY | 42 | 60% | 2% | 46 |
| 10 | WILD CAPTURED CHIMPANZEE | 37 | 74% | 1% | 28 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF MEDICAL PRIMATOLOGY | 22 | 12% | 10% | 182 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| AIDS - AIDS as a zoonosis: Scientific and public health implications | 2000 | 573 | 62 | 65% |
| Natural SIV Hosts: Showing AIDS the Door | 2012 | 59 | 68 | 59% |
| The evolution of HIV-1 and the origin of AIDS | 2010 | 57 | 51 | 61% |
| The history of SIVS and AIDS: Epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa | 2004 | 71 | 180 | 71% |
| Origin and Diversity of Human Retroviruses | 2014 | 3 | 85 | 41% |
| Simian immunodeficiency virus infection of chimpanzees | 2005 | 77 | 81 | 64% |
| What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? | 2004 | 56 | 73 | 77% |
| Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population | 2012 | 28 | 135 | 43% |
| Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses | 2006 | 83 | 364 | 43% |
| Live attenuated HIV vaccines: pitfalls and prospects | 2004 | 62 | 71 | 66% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MARION MERRELL DOW VIRAL PATHOGENESIS | 12 | 45% | 1.1% | 20 |
| 2 | PRIMATE MODELSAKYO KU | 6 | 53% | 0.4% | 8 |
| 3 | AIDS ABORATING | 6 | 100% | 0.2% | 4 |
| 4 | STELLAR CHANCE S 705 | 5 | 63% | 0.3% | 5 |
| 5 | PRIMATE MODEL | 5 | 32% | 0.6% | 12 |
| 6 | UNITE BIOL RETROVIRUS | 4 | 21% | 0.9% | 17 |
| 7 | PROJECT P ICA | 3 | 50% | 0.3% | 5 |
| 8 | EXPT MED SURG PRIMATES | 3 | 57% | 0.2% | 4 |
| 9 | TULANE REG PRIMATE | 3 | 21% | 0.7% | 14 |
| 10 | UMR036 | 3 | 100% | 0.2% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000189685 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |
| 2 | 0.0000174004 | TYPE D RETROVIRUSES//TYPE D SIMIAN RETROVIRUS//SRV 2 |
| 3 | 0.0000147349 | HIV 2//HIV 2 INFECTION//GUINEA BISSAU |
| 4 | 0.0000135652 | UNITE RETROVIROL MOL//ENTROPY EVOLUTION RATE//HIV 1 MOTHER TO CHILD TRANSMISSION |
| 5 | 0.0000128216 | PARTNERS AIDS//HIV PATHOGENESIS PROGRAMME//DORIS DUKE MED |
| 6 | 0.0000114967 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER |
| 7 | 0.0000110877 | NEF//HIV 1 NEF//HIV NEF |
| 8 | 0.0000099939 | MICROBIAL TRANSLOCATION//HIV ENTEROPATHY//ISOSPORA BELLI |
| 9 | 0.0000098992 | AOTUS NANCYMAAE//AOTUS//COLOMBIAN PERUVIAN AMAZON |
| 10 | 0.0000092791 | HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR |